- Home
- BEAT vs JMM Comparison
BEAT vs JMM Comparison
Compare BEAT & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- JMM
- Stock Information
- Founded
- BEAT 2015
- JMM 1988
- Country
- BEAT United States
- JMM United States
- Employees
- BEAT N/A
- JMM N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- JMM Trusts Except Educational Religious and Charitable
- Sector
- BEAT Technology
- JMM Finance
- Exchange
- BEAT Nasdaq
- JMM Nasdaq
- Market Cap
- BEAT 51.1M
- JMM 60.4M
- IPO Year
- BEAT 2021
- JMM N/A
- Fundamental
- Price
- BEAT $1.27
- JMM $6.35
- Analyst Decision
- BEAT Buy
- JMM
- Analyst Count
- BEAT 1
- JMM 0
- Target Price
- BEAT $8.00
- JMM N/A
- AVG Volume (30 Days)
- BEAT 71.4K
- JMM 16.1K
- Earning Date
- BEAT 08-13-2025
- JMM 01-01-0001
- Dividend Yield
- BEAT N/A
- JMM 5.44%
- EPS Growth
- BEAT N/A
- JMM N/A
- EPS
- BEAT N/A
- JMM N/A
- Revenue
- BEAT N/A
- JMM N/A
- Revenue This Year
- BEAT N/A
- JMM N/A
- Revenue Next Year
- BEAT N/A
- JMM N/A
- P/E Ratio
- BEAT N/A
- JMM N/A
- Revenue Growth
- BEAT N/A
- JMM N/A
- 52 Week Low
- BEAT $1.17
- JMM $5.29
- 52 Week High
- BEAT $3.48
- JMM $6.10
- Technical
- Relative Strength Index (RSI)
- BEAT 38.33
- JMM 54.68
- Support Level
- BEAT $1.24
- JMM $6.20
- Resistance Level
- BEAT $1.34
- JMM $6.45
- Average True Range (ATR)
- BEAT 0.07
- JMM 0.13
- MACD
- BEAT 0.01
- JMM -0.00
- Stochastic Oscillator
- BEAT 41.18
- JMM 57.69
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.